David D. Bushart

502 total citations
13 papers, 317 citations indexed

About

David D. Bushart is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, David D. Bushart has authored 13 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in David D. Bushart's work include Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Ion channel regulation and function (3 papers). David D. Bushart is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Ion channel regulation and function (3 papers). David D. Bushart collaborates with scholars based in United States, Switzerland and Sweden. David D. Bushart's co-authors include Vikram G. Shakkottai, Geoffrey G. Murphy, Ravi Chopra, Vikrant Singh, Heike Wulff, Hayley S. McLoughlin, Henry L. Paulson, A. K. Savchenko, Gary D. Smith and Albert R. La Spada and has published in prestigious journals such as Neuron, PLoS ONE and Human Molecular Genetics.

In The Last Decade

David D. Bushart

13 papers receiving 315 citations

Peers

David D. Bushart
David D. Bushart
Citations per year, relative to David D. Bushart David D. Bushart (= 1×) peers Paweł M. Świtoński

Countries citing papers authored by David D. Bushart

Since Specialization
Citations

This map shows the geographic impact of David D. Bushart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Bushart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Bushart more than expected).

Fields of papers citing papers by David D. Bushart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Bushart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Bushart. The network helps show where David D. Bushart may publish in the future.

Co-authorship network of co-authors of David D. Bushart

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Bushart. A scholar is included among the top collaborators of David D. Bushart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Bushart. David D. Bushart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Bushart, David D. & Vikram G. Shakkottai. (2022). Vulnerability of Human Cerebellar Neurons to Degeneration in Ataxia-Causing Channelopathies. Frontiers in Systems Neuroscience. 16. 908569–908569. 4 indexed citations
3.
Torrente, Daniel, Enming J. Su, Linda Fredriksson, et al.. (2022). Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke. Translational Stroke Research. 13(5). 801–815. 17 indexed citations
4.
Chopra, Ravi, David D. Bushart, Dhananjay Yellajoshyula, et al.. (2020). Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1. Human Molecular Genetics. 29(19). 3249–3265. 14 indexed citations
5.
Bushart, David D., et al.. (2020). A Chlorzoxazone‐Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1. Movement Disorders. 36(3). 622–631. 23 indexed citations
6.
Bushart, David D., Hongjiu Zhang, Yuanfang Guan, et al.. (2020). Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3. The Cerebellum. 20(1). 41–53. 16 indexed citations
7.
Schultz, Mark L., Maria V. Fawaz, Todd Hollon, et al.. (2019). Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases. BMC Medicine. 17(1). 200–200. 18 indexed citations
8.
Moore, Lauren R., Laura Keller, David D. Bushart, et al.. (2019). Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line. Stem Cell Research. 39. 101504–101504. 25 indexed citations
9.
Bushart, David D., Paweł M. Świtoński, Mibo Tang, et al.. (2019). Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7. Neuron. 105(4). 630–644.e9. 53 indexed citations
10.
Bushart, David D. & Vikram G. Shakkottai. (2018). Ion channel dysfunction in cerebellar ataxia. Neuroscience Letters. 688. 41–48. 48 indexed citations
11.
Bushart, David D., Ravi Chopra, Vikrant Singh, et al.. (2018). Targeting potassium channels to treat cerebellar ataxia. Annals of Clinical and Translational Neurology. 5(3). 297–314. 46 indexed citations
12.
Chopra, Ravi, David D. Bushart, & Vikram G. Shakkottai. (2018). Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1. PLoS ONE. 13(5). e0198040–e0198040. 18 indexed citations
13.
Bushart, David D., Geoffrey G. Murphy, & Vikram G. Shakkottai. (2016). Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.. PubMed. 4(2). 25–25. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026